RO7062931

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Chronic Hepatitis BHealthy Participants

Phase 1

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B

CompletedNCT03038113

Hoffmann-La RocheChronic Hepatitis B

Start: 2017-02-06End: 2019-10-18Updated: 2020-12-24

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RO7062931 in Healthy Chinese Volunteers.

CompletedNCT03505190

Hoffmann-La RocheHealthy Participants

Start: 2018-05-03End: 2019-07-05Updated: 2020-08-03